Atlas Trials

Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function

Clinical trial NCT01923857 · COMPLETED

Trial details

NCT number
NCT01923857
Sponsor
Repros Therapeutics Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Secondary Hypogonadism
Start date
2013-08-01
Primary completion
2014-08-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.